Wednesday, August 24, 2016

BRIEF-TG Therapeutics announces orphan drug designation for TGR-1202 for treatment of chronic lymphocytic leukemia

* TG Therapeutics announces orphan drug designation for

TGR-1202 for treatment of chronic lymphocytic leukemia

Source text for Eikon:

Further company coverage:

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)